Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN(®) in combination with chemotherapy

Of the most prevalent solid tumors with advanced disease, prostate and ovarian cancer and non-small cell lung carcinoma have the fewest therapeutic options. Herein, we report the case of a 63-year-old male with metastatic prostate adenocarcinoma showing substantial remission post-administration of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Chaitanya, Bagga, Jasmine, Chiliveru, Srikanth, Kohli, Sakshi, Bharadwaj, Asmi, Jain, Minish, Inamdar, Shriram, Sharan, Bandana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900976/
https://www.ncbi.nlm.nih.gov/pubmed/31827897
http://dx.doi.org/10.2144/fsoa-2019-0086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900976/
https://www.ncbi.nlm.nih.gov/pubmed/31827897
http://dx.doi.org/10.2144/fsoa-2019-0086

Ejemplares similares